What Is CBG? The Mother of All Cannabinoids Explained (2026 Guide)

CBG (cannabigerol) is a naturally occurring cannabinoid found in cannabis and hemp plants. It is non-psychoactive — it does not produce a high. CBG is typically present in very low concentrations (less than 1%) in most mature cannabis strains because it converts into other cannabinoids (THC, CBD, CBC) as the plant grows.

CBG was first isolated in 1964 by Israeli researchers Yechiel Gaoni and Raphael Mechoulam — the same team that discovered THC. Despite being identified over 60 years ago, CBG research lagged behind THC and CBD until the late 2010s when cannabis breeders developed high-CBG strains that made commercial production viable.

Today, CBG is available in flower, oil, gummies, capsules, and topical products. It is gaining popularity among consumers looking for cannabis benefits without the psychoactive effects of THC or the sedation some people experience with CBD.

All cannabinoids start as CBGA (cannabigerolic acid) — the acidic precursor form of CBG. As the cannabis plant matures, specific enzymes convert CBGA into three major cannabinoid precursors:

• THCA → becomes THC (the psychoactive compound)
• CBDA → becomes CBD (the wellness compound)
• CBCA → becomes CBC (a lesser-known cannabinoid)

This is why CBG is called the “mother” — without it, none of the other major cannabinoids would exist. By the time most cannabis plants are harvested, nearly all the CBGA has been converted, leaving only trace amounts of CBG in the final product.

To produce CBG-rich products, growers either breed special high-CBG strains where the conversion enzymes are less active, or they harvest plants early before CBGA has fully converted. Both approaches are more expensive than standard cannabis cultivation, which is why CBG products tend to cost more.

While CBG is the precursor to THC, the two cannabinoids produce very different effects:

• THC produces a psychoactive high by binding strongly to CB1 receptors in the brain. CBG does not produce a high because its affinity for CB1 receptors is much weaker.
• CBG may actually counteract some THC effects. Research suggests CBG may act as a buffer against THC-induced anxiety and paranoia by competing for the same receptor sites.
• Both stimulate appetite, but through different mechanisms. THC activates hunger signals centrally (in the brain), while CBG may affect appetite through peripheral pathways.
• Both have analgesic (pain-relieving) properties, making combination products attractive for pain management without strong psychoactive effects.

For a deeper understanding of how cannabinoids work in your body, read our endocannabinoid system guide.

CBG research is growing rapidly. Key published studies include:

• Inflammatory Bowel Disease (2013): Borrelli et al. in Biochemical Pharmacology found CBG reduced inflammation in a mouse model of colitis, suggesting potential for IBD treatment.
• MRSA Antibacterial Activity (2020): Farha et al. in ACS Infectious Diseases demonstrated CBG's potent activity against methicillin-resistant Staphylococcus aureus (MRSA), one of the most dangerous antibiotic-resistant bacteria.
• Huntington's Disease Neuroprotection (2015): Valdeolivas et al. in Neurotherapeutics found CBG was neuroprotective in an experimental model of Huntington's disease.
• Bladder Dysfunction (2015): Pagano et al. found CBG reduced bladder contractions, suggesting potential for overactive bladder treatment.
• Appetite Stimulation (2016): Brierley et al. in Psychopharmacology demonstrated CBG increased food intake in rats without psychoactive effects.

Important disclaimer: These are preclinical studies (animal models and lab experiments). Human clinical trials are limited. CBG products are not FDA-approved for treating any medical condition. Consult a healthcare provider before using CBG for health purposes.

CBG is consumed the same way as CBD products. Here are the main methods:

• Sublingual tinctures: Place drops under your tongue, hold for 60-90 seconds, then swallow. Effects in 15-30 minutes. Most precise dosing method.
• Smoking or vaping CBG flower: Immediate effects. Full entourage effect with terpenes. Good for users who prefer inhalation.
• Gummies or capsules: Convenient, pre-dosed, discreet. Effects in 30-60 minutes. Good for daily wellness routines.
• Topicals: CBG-infused creams or balms applied directly to skin. Used for localized pain or inflammation. Does not enter the bloodstream.

Starting dose: Begin with 5-10mg of CBG per day and increase gradually. CBG is well-tolerated by most people with no reported serious side effects. Some users take 25-50mg daily for wellness purposes.

CBG products are available at licensed NJ dispensaries and through hemp retailers. At The Library in West Orange, we carry CBG-containing products including ratio formulations and full-spectrum products that include natural CBG alongside THC and CBD.

Check our online menu for current availability. Our budtenders can help you understand which cannabinoid profile is best suited for your goals. Visit us at 5 Washington Street, West Orange, NJ 07052 or call (862) 786-0886.

Explore more cannabinoid education: What Is CBN? | What Is THCA? | What Is Delta-8? | Endocannabinoid System Explained